HaEmek Medical Center (Site 3003)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Melanoma

Running trials

• Active, not recruiting

  A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

  NCT06961006· Phase 2· Merck Sharp & Dohme LLC· Source